Home›Companies›Biotech & Pharma›ORF Biologics

ORF Biologics, Inc.

Designs and makes proteins and other biological products for researchers and drug developers.

Updated Nov 9, 2026·Latest SEC filing Jul 31, 2026·Suggest an edit

About ORF Biologics

ORF Biologics is a private company based in Tiffin, Iowa, incorporated in 2024 in Iowa. It has reported $1,734,220 raised in two offerings on Form D since December 2024. Its chief executive is Anant Kamath.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 23, 2026Jul 31, 2026$1,734,220of $2.5M target17$102KEquityRule 506(b)Form D ↗
Not yetDec 12, 2024$0of $2.5M target0—EquityRule 506(b)Form D ↗
Total, two offerings$1,734,220

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ORF Biologics's Form D filed Jul 31, 2026.

JK
Jay Kamath
Executive officer
ST
Sara Ternes
Principal Investigator and Chief Operating Officer
RB
Roger Baker
Director
AK
Anant Kamath
CEO and director
NT
JH

Earlier filings also listed Stephen Hanson (executive officer and director, last listed Dec 2024).

Sources

  1. SECORF Biologics, Inc. filing history
  2. CompanyPrivacy policy
  3. CompanyRare disease program announcement
  4. CompanyCell products announcement